Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Colorectal Neoplasms and HPGD[original query] |
---|
Association of hydroxyprostaglandin dehydrogenase 15-(NAD) (HPGD) variants and colorectal cancer risk. Carcinogenesis 2011 Feb 32 (2): 190-6. Frank Bernd, Hoeft Birgit, Hoffmeister Michael, Linseisen Jakob, Breitling Lutz P, Chang-Claude Jenny, Brenner Hermann, Nieters Alexand |
A study of prostaglandin pathway genes and interactions with current nonsteroidal anti-inflammatory drug use in colorectal adenoma. Cancer prevention research (Philadelphia, Pa.) 2012 Jun 5 (6): 855-63. Edwards Todd L, Shrubsole Martha J, Cai Qiuyin, Li Guoliang, Dai Qi, Rex Douglas K, Ulbright Thomas M, Fu Zhenming, Murff Harvey J, Smalley Walter, Ness Reid, Zheng W |
Genetic variability in key genes in prostaglandin E2 pathway (COX-2, HPGD, ABCC4 and SLCO2A1) and their involvement in colorectal cancer development. PloS one 2014 9 (4): e92000. Pereira Carina, Queirós Sara, Galaghar Ana, Sousa Hugo, Pimentel-Nunes Pedro, Brandão Catarina, Moreira-Dias Luís, Medeiros Rui, Dinis-Ribeiro Már |
Influence of Genetic Polymorphisms in Prostaglandin E2 Pathway (COX-2/HPGD/SLCO2A1/ABCC4) on the Risk for Colorectal Adenoma Development and Recurrence after Polypectomy. Clinical and translational gastroenterology 2016 7 (9): e191. Pereira Carina, Queirós Sara, Galaghar Ana, Sousa Hugo, Marcos-Pinto Ricardo, Pimentel-Nunes Pedro, Brandão Catarina, Medeiros Rui, Dinis-Ribeiro Már |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 04, 2023
- Content source: